In Partnership with ALCSI
Lung Cancer Screening Risk Assessment
by Siddharth Chinthapalli and Aditya Geeniga
Takes under 2 minutes  ·  100% confidential  ·  Bilingual
1 in 16
Americans will be diagnosed with lung cancer in their lifetime
80%
5-year survival rate when lung cancer is caught at Stage I
77%
of lung cancers are diagnosed at a late, less treatable stage
3×
more deaths than breast and colon cancer combined annually
Why take this screening today?
Early detection saves lives. LDCT screening reduces lung cancer mortality by up to 20% in high-risk individuals (NLST trial, NEJM 2011).
Clinically validated. Uses the Bach and PLCOm2012 models — the two most widely validated lung cancer risk tools used in hospitals worldwide.
Quick & non-invasive. No blood draw, no appointment needed. Answer a few questions and receive your personalised risk result instantly.
Support research. Your de-identified responses contribute to the ALCSI national lung cancer screening database.
💡 The U.S. Preventive Services Task Force recommends annual lung cancer screening for adults aged 50–80 who have a 20+ pack-year smoking history and currently smoke or quit within the past 15 years.

Educational purposes only · Solo fines educativos
American Lung Cancer Screen Initiative (ALCSI)